Latest Breaking News On - பத்திரங்கள் ப்ரைவேட் வரையறுக்கப்பட்டவை - Page 1 : comparemela.com

The public issue received bids for 4.17 crore shares against total 1.50 crore shares on offer Brokerages are positive on prospects of Glenmark Life Sciences IPO. BusinessToday.In Updated Jul 28, 2021, 10:27 AM IST The initial public offer (IPO) of Glenmark Life Sciences was fully subscribed on its first day on Tuesday. The public issue received bids for 4.17 crore shares against total 1.50 crore shares on offer. The portion reserved for retail investors was subscribed 5.16 times. Portion allocated for non-institutional investors was subscribed 85 percent. Qualified institutional buyers put in bids for 10,540 equity shares against their reserved portion of 42.42 lakh equity shares. The IPO will close on July 29. Price band for the offer has been fixed at Rs 695-720 per equity share.

Maruti suzukiGlenmark pharmaKotak mahindra capital companyCapital advisors ltdInsurance companyGlenmark life sciencesCopthall mauritius investment ltdGovernment pension fund globalIndusind bankTata motorsOaktree emerging markets equity fundBofa securities india ltdGoldman sachs india securities privateKuber india fundInvestment fundsReliance general insurance company